PharmaEngine (4162.TWO) Earnings Analysis
PharmaEngine (4162.TWO) next reports earnings on 2026-07-30, consensus EPS 0.98 TWD. Last quarter (2026-03-03) it beat with EPS 0.91 TWD vs 0.79 TWD est (+15.2%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 22.72.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4162.TWO next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.98 TWD |
| Revenue estimate | 0.25B |
4162.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | 0.91 TWD | 0.79 TWD | +15.2% | Beat |
| 2025-10-30 | 0.95 TWD | 0.68 TWD | +39.7% | Beat |
| 2024-10-31 | 0.64 TWD | 0.67 TWD | -4.5% | Miss |
| 2024-07-25 | 1.11 TWD | 0.4 TWD | +177.5% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
4162.TWO valuation and analyst view
| Trailing P/E | 22.72 |
|---|---|
| Trailing EPS | 2.941 TWD |
| Price / book | 1.90 |
| Dividend yield | 8.98% |
| Market cap | 9.83B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is PharmaEngine (4162.TWO)'s next earnings date?
PharmaEngine is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.98 TWD and revenue estimate of 0.25B.
Did 4162.TWO beat earnings last quarter?
In its 2026-03-03 report, 4162.TWO posted EPS of 0.91 TWD versus a 0.79 TWD estimate — a beat of 15.2%.
What is 4162.TWO's earnings track record?
Over the last 4 reported quarters with consensus data, 4162.TWO beat estimates 3 times (75%).
What is 4162.TWO's current P/E ratio and EPS?
4162.TWO trades at a trailing P/E of 22.72 on trailing EPS of 2.9409926432205573 TWD.
What do analysts rate 4162.TWO?
4162.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.